8-K: Owlet Reports Strong Q2, Raises 2025 Guidance, Announces CEO Transition

Owlet, Inc. reported robust second quarter 2025 financial results, exceeding expectations and raising full-year guidance, alongside a planned CEO transition.

Summary

• Second quarter 2025 revenue reached $26.1 million, marking a 25.9% increase compared to Q2 2024.
• Gross margin for Q2 2025 improved by 180 basis points to 51.3% from 49.5% in Q2 2024.
• Adjusted EBITDA for Q2 2025 was $0.3 million, an improvement of $0.2 million compared to $0.1 million in Q2 2024.
• Net loss for Q2 2025 was $37.6 million, primarily due to a $34.8 million non-cash, mark-to-market common stock warrant liability adjustment.
• The Owlet360 subscription service surpassed 66,000 paying subscribers, showing steady growth in monthly recurring revenue, attach rate, retention rate, and consumer satisfaction.
• Full year 2025 revenue guidance was increased to a range of $97 million to $100 million, representing 24% to 28% year-over-year growth.
• The company now expects to be Adjusted EBITDA profitable for the full year 2025.
• Kurt Workman will transition from Chief Executive Officer to Executive Chairman of the Board, effective October 1, 2025.
• Jonathan Harris, current President, will succeed Kurt Workman as Chief Executive Officer, effective October 1, 2025.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to strong operational performance, significant revenue growth, gross margin expansion, and improved Adjusted EBITDA. The increased full-year guidance and expectation of Adjusted EBITDA profitability are strong indicators. While a large net loss was reported, it was primarily due to a non-cash accounting adjustment. The planned and well-communicated CEO transition also adds to positive sentiment.

Positives

• Revenue increased by 25.9% year-over-year to $26.1 million in Q2 2025, indicating strong sales performance.
• Gross margin expanded by 180 basis points to 51.3% in Q2 2025, reflecting improved product mix, lower costs, and fixed cost absorption.
• Adjusted EBITDA improved to $0.3 million in Q2 2025, demonstrating progress towards profitability.
• The Owlet360 subscription service is growing, with over 66,000 paying subscribers and positive trends in key metrics like monthly recurring revenue and retention.
• Full year 2025 revenue guidance was increased to $97 million to $100 million, signaling management's confidence in continued growth.
• The company now expects to achieve full-year 2025 Adjusted EBITDA profitability.
• The CEO transition is a planned succession, with the outgoing CEO remaining as Executive Chairman and the new CEO having a proven track record within the company.

Negatives

• Reported a significant net loss of $37.6 million in Q2 2025, primarily driven by a $34.8 million non-cash common stock warrant liability adjustment.
• Net loss per share was $2.37 in Q2 2025, a substantial increase from $0.30 in Q2 2024.
• Total liabilities increased to $108.0 million as of June 30, 2025, from $66.3 million as of December 31, 2024, largely due to the increase in common stock warrant liabilities.
• Total stockholders' deficit widened to $(59.2) million as of June 30, 2025, from $(29.8) million as of December 31, 2024.

Risks

• The regulatory pathway for Owlet's products, including submissions to and decisions from regulators like the FDA and international bodies, and the ability to maintain regulatory approval or certification.
• Competition within the market and the company's ability to achieve profitable growth and manage that growth effectively.
• The ability to enhance future operating and financial results or secure additional financing to continue as a going concern.
• Risks associated with current loan and debt agreements, including compliance with debt covenants, restrictions on capital access, overall debt levels, and the ability to generate sufficient cash flows for debt service.
• The ability to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate, meet customer demands, and adapt to changes in consumer preferences and retail trends.
• The ability to acquire, defend, and protect intellectual property, and satisfy regulatory requirements concerning privacy and data protection, including risks of breaches and data loss.
• The ability to maintain relationships with customers, manufacturers, and suppliers, and to retain key management and employees.
• Challenges in upgrading and maintaining information technology systems.
• Changes in applicable laws or regulations in the United States and other jurisdictions.
• The impact of and disruption to business, financial condition, operations, supply chain, and logistics due to economic and other conditions beyond the company's control, such as health epidemics, macro-economic uncertainties, tariffs, trade restrictions, social unrest, hostilities, natural disasters, or other catastrophic events.
• Adverse effects from other economic, business, regulatory, or competitive factors, including changes in discretionary consumer spending and preferences.

Future Outlook

The company has increased its full year 2025 revenue guidance to a range of $97 million to $100 million, representing 24% to 28% year-over-year growth. Gross margins are expected to be in the range of 46% to 50%, including the impact of new expected tariff costs. Owlet fully expects to achieve Adjusted EBITDA profitability for the full year 2025, signaling a positive trajectory for operational efficiency and financial health.

Management Comments

• "Our exceptional team continues to execute at a high level as Q2 outperformed expectations across all key metrics."
• "We drove strong revenue of $26.1 million in the quarter, growing 26% year-over-year, contributing to our largest first half revenue performance in Company history."
• "We also delivered another quarter of year-over-year gross margin expansion and adjusted EBITDA improvement, reflecting the healthy momentum in the business."
• "Owlet360 subscription continues to trend positively, recently surpassing 66,000 paying subscribers with steady growth in monthly recurring revenue, attach rate, retention rate, and consumer satisfaction."
• "With the ongoing growth in our core business, and the exciting momentum in Owlet360 subscription, we believe Owlet is uniquely positioned to capture the addressable market opportunities in pediatric health, as we continue our evolution from a hardware company into a comprehensive pediatric health platform."
• "I founded Owlet over 12 years ago because I believe that every baby should have access to medical-grade health monitors at home, and we’ve never been closer to that vision."
• "This organizational change will allow me to focus more deeply on the things I’m most passionate about—expanding access to Owlet’s mission and helping guide the Company’s long-term strategy as we continue to grow."
• "Owlet could not have a better CEO going forward. Jonathan is an extremely accomplished executive with a proven ability to consistently deliver value to a full range of stakeholders."
• "Jonathan’s leadership and commitment to Owlet’s mission has already made an incredible impact on the company over the past two years with him leading our global go-to-market directly following FDA and CE mark clearances, spearheading international growth and distribution, standing up our Owlet360 subscription offering, and driving a more focused, streamlined organization."
• "Undoubtedly, the momentum and performance we’ve delivered in recent quarters are a direct result of Jonathan’s impact on the business and his valuable leadership."
• "Jonathan has been pivotal in the transformation of Owlet as a comprehensive pediatric health platform, and he is ideally suited to lead as Owlet’s CEO through this next phase of growth."

Industry Context

Owlet operates in the growing digital health and smart infant monitoring market, positioning itself as a pioneer in this space. The company's strategic shift from a pure hardware provider to a comprehensive pediatric health platform, emphasized by the growth of its Owlet360 subscription service, aligns with broader industry trends towards recurring revenue models and integrated health solutions. The focus on FDA-authorized medical wearables suggests a move towards higher-value, regulated products, differentiating it from general consumer electronics and potentially capturing a larger share of the pediatric health market.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to benchmark Owlet's performance against global industry standards. However, the company states it uses non-GAAP financial measures for benchmarking against its peers and competitors internally.

Management Changes

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased guidance, and a clear succession plan for leadership, potentially leading to increased investor confidence and share price appreciation. However, the significant non-cash net loss and widening stockholders' deficit remain a concern.
• Employees: The planned leadership transition and positive business momentum may provide stability and clarity regarding the company's future direction.
• Customers: Continued growth in the Owlet360 subscription and focus on a comprehensive pediatric health platform suggest ongoing product development and service enhancements.
• Suppliers/Manufacturers: Increased revenue and production imply continued demand for their services and products.
• Creditors: The increase in the line of credit and the company's goal of Adjusted EBITDA profitability for the full year may indicate a more stable financial position for debt servicing, though the overall increase in liabilities warrants monitoring.

Next Steps

• Jonathan Harris will officially succeed Kurt Workman as Chief Executive Officer on October 1, 2025.
• Kurt Workman will transition to Executive Chairman of the Board on October 1, 2025.
• The company will continue its evolution from a hardware company into a comprehensive pediatric health platform, focusing on expanding access to its mission and guiding long-term strategy.

Key Dates

Recommendation

The company demonstrated strong operational performance in Q2 2025 with significant revenue growth and gross margin expansion. The positive Adjusted EBITDA and the increased full-year guidance, including the expectation of full-year Adjusted EBITDA profitability, signal a robust business trajectory. While the reported net loss is substantial, it is primarily due to a non-cash accounting adjustment related to warrant liabilities, which does not reflect core operational health. The planned and smooth CEO transition, with the co-founder remaining as Executive Chairman, provides continuity and strategic focus. These factors suggest a positive outlook for a growth-oriented investor, indicating the stock is likely to appreciate.

Keywords

Owlet, Smart Infant Monitoring, Pediatric Health, Wearables, FDA-authorized, Q2 Earnings, Financial Results, CEO Transition, Subscription Service, OWLT, NYSE